July - September 2017
-
DOI: 10.65564/pjim.30bf8fc178
Articles in this Issue
Why Get Published?
Authors: Joven Q. Tanchuco
DOI: 10.65564/pjim.e0c610b354 | Published: September 2017
Emphasizes the ethical, professional, and practical importance of publishing research findings, advocates responsible dissemination through peer-reviewed channels, and encourages physicians and researchers to share their data to advance scientific knowledge and improve patient care.
Package Insert, Drug Labeling and Standard of Care
Authors: Rodel V. Capule
DOI: 10.65564/pjim.912554beef | Published: September 2017
Clarifies the legal and clinical role of FDA-approved drug labeling, including package inserts, patient information leaflets, and other labeling materials, by examining jurisprudence that distinguishes these documents from the medical standard of care and emphasizing the necessity of expert testimony in establishing physician liability for alleged deviations from labeling recommendations.
Association of the Platelet–Lymphocyte Ratio (PLR) with Outcomes in Patients Admitted for Acute Coronary Syndrome: The PLACS Study
Authors: Lauro L. Abrahan IV, Jaime Alfonso M. Aherrera, John Daniel A. Ramos, Paul Ferdinand Reganit, Felix Eduardo Punzalan
DOI: 10.65564/pjim.130ebb8f67 | Published: September 2017
Patients with acute coronary syndrome (ACS) exhibit a wide spectrum of early risk of death (one to 10 percent). High platelet counts may indicate a propensity for platelet-rich thrombi. Lymphocyte counts drop during ACS due to stress-induced cortisol release. Combining these two markers, recent studies have found that the platelet-to-lymphocyte ratio (PLR) is associated with adverse cardiac events among patients with ACS, but local data is limited. The objective of this study is to determine if an elevated PLR taken on admission is associated with higher rates of adverse cardiac events.
Clinico-pathologic Profile and Clinical Outcomes of Patients with Indolent Lymphoma at the Cancer Institute of the Philippine General Hospital: A Seven-year Experience
Authors: Paolo R. dela Rosa, Charles Vincent O. Uy, John Anthony D. Tindoc, Corazon A. Ngelangel
DOI: 10.65564/pjim.7b25de5133 | Published: September 2017
Indolent lymphoma (IL) is a slowly growing lymphoma, generally refractory to conventional chemotherapy. There are several types of IL, which includes follicular lymphoma (FL), marginal zone lymphoma (MZL), small lymphocytic lymphoma (SLL), mantle cell lymphoma (MCL), and waldenstrom macroglobulinemia/ lymphoplasmacytic lymphoma (WM/LPL). Presently, there are no known data in the Philippines on IL. This study is done to determine the clinico-pathologic profile and outcomes of Filipino patients with IL.
Barriers to Hand Hygiene Compliance in the Medicine Wards and Intensive Care Unit of a Tertiary Teaching Hospital in the Philippines
Authors: Anna Flor G. Malundo, Regina P. Berba
DOI: 10.65564/pjim.1606709121 | Published: September 2017
Healthcare associated infections (HCAI) continue to be major problems in our institution. Studies have shown that hand hygiene remain to be the primary measure that prevents HCAI. This study aimed to measure hand hygiene compliance rate and determine factors affecting compliance.
Four-year Clinical Outcomes of Filipino Patients with or at Risk for Atherothrombotic Events from the REACH Registry
Authors: Maria Teresa B. Abola, Felix Eduardo R. Punzalan
DOI: 10.65564/pjim.54fe3d0b6a | Published: September 2017
Patients with established atherothrombotic disease (EAD) or those with only atherothrombotic risk factors are at high risk for cardiovascular events and death. There are scant data on the clinical profile of stable Filipino patients with or at risk for atherothrombosis and their long-term outcomes. The authors'objective is to present the baseline clinical profile and four-year cardiovascular outcomes in Filipino outpatients with EAD and those with multiple atherothrombotic risk factors in comparison to the Asian and Global populations
The Efficacy of Oral Trimetazidine in Preventing Contrast- Induced Nephropathy Among Patients Undergoing Elective Coronary Procedures: A Meta-analysis of Randomized Controlled Trials
Authors: Roland Reuben B. Angeles, Rich Ericson C. King, John D. Anonuevo, Elaine B. Alajar, Jose Eduardo D. Duya
DOI: 10.65564/pjim.9979f2b3fc | Published: September 2017
Contrast-induced nephropathy (CIN) is a serious but preventable complication of coronary procedures. Trimetazidine (TMZ) has recently been explored for use in preventing post-procedural CIN due to its cellular anti-ischemic and antioxidant properties. The objective is to assess the efficacy of oral TMZ in the prevention of contrast induced nephropathy during elective coronary angiography and PCI among patients with renal impairment.
Non-invasive Ventilation Versus Conventional Oxygen Therapy in Immunocompromised Patients: A Meta-analysis
Authors: Ulysses King Gopez, Karen Flores, Ralph Elvi Villalobos, Norman Maghuyop
DOI: 10.65564/pjim.a54b824187 | Published: September 2017
Respiratory failure is common in immuno-compromised patients. Intubation and mechanical ventilation (MV) is the mainstay of treatment but is associated with increased risk of pneumonia and other complications. Non-invasive ventilation (NIV) is an alternative to MV in a select group of patients and aims to avoid the complications of MV. In these patients, we performed a meta-analysis on the effect of NIV versus conventional oxygen therapy in reducing intubation rates and other important clinical outcomes.
Blood Eosinophilia as Predictor for Patient Outcomes in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Authors: Ralph Elvi M. Villalobos, Aileen D. Wang
DOI: 10.65564/pjim.355fc2534e | Published: September 2017
The eosinophilic phenotype of chronic ob-structive pulmonary disease (COPD) has been demonstrated to respond better to corticosteroids and associated with better outcomes. This review aims to clarify the correlation of blood eosinophilia and outcomes patients with COPD exacerbations.
The Role of Prophylactic Renin-angiotensin System Inhibitors for the Prevention of Anthracycline-induced Cardiotoxicity Among Adult Cancer Patients: A Meta-analysis
Authors: Karen Anjela M. Mondragon, Jhoanna Rose H. Velasquez, Danielle Benedict L. Sacdalan, Lauro L. Abrahan IV, Irisyl O. Real, Felix Eduardo R. Punzalan
DOI: 10.65564/pjim.86bec13e8f | Published: September 2017
Anthracycline is a cornerstone in the treatment of various cancers. One major limitation to its use is cardiotoxicity. Renin angiotensin system (RAS) inhibitors have been shown to attenuate myocardial injury, initial data is promising in its use as prophylaxis for anthracycline-induced cardiotoxicity. The aim of the study is to determine effectiveness of prophylactic RAS inhibitors in preventing anthracycline-induced cardiotoxicity and adverse cardiac events among adult cancer patients
Prognostic Impact of Coronary Collaterals in Acute Coronary Syndrome (PICC-ACS): A Meta-analysis of Observational Studies
Authors: John Daniel A. Ramos, Jaime Alfonso M. Aherrera, Lowe L. Chiong,Mark A. Vicente, Felix Eduardo R. Punzalan, Richard Henry P. Tiongco
DOI: 10.65564/pjim.d5622d5964 | Published: September 2017
The coronary collateral circulation (CCC) is an alternative source of blood supply in coronary artery disease (CAD). The prognostic value of the presence of CCC at the time of acute coronary syndrome (ACS) is undefined with regards to hard outcomes, particularly reduction in mortality. The study's aim is to determine if the presence of CCC demonstrated by coronary angiography during an ACS is associated with a reduction in mortality.
Efficacy of Ranolazine in Lowering HbA1c in Patients with Type 2 Diabetes Mellitus: A Meta-analysis
Authors: Everly Faith Ramos, Angelique Bea Uy, Aldrin B. Loyola
DOI: 10.65564/pjim.178e62ed8e | Published: September 2017
The objective of this study is to determine the efficacy and safety of Ranolazine in HbA1c lowering as an add-on therapy to existing anti-diabetic regimen.
Weathering an Adenosine Insensitive Right Ventricular Outflow Tract Ventricular Tachycardia (Ado-insensitive RVOT VT) Storm in an Adolescent Female: A Case Report
Authors: Jose Eduardo DL. Duya, Nashiba Daud, Joerelle V. Mojica, Dioscoro DC. Bayani II,Muriel A. Morilla, Giselle G. Gervacio,Michael Joseph Agbayani, Louisa Go, Olympia Q. Malanyaon
DOI: 10.65564/pjim.df7915f181 | Published: September 2017
Ventricular tachycardias (VT) are commonly associated with structural heart disease. However, 10% of VTs have no identifiable cause. Right ventricular outflow tract ventricular tachycardia (RVOT VT), a small subgroup of idiopathic VTs localized in the right ventricular outflow tract is highly sensitive to adenosine (ADO). Only 11% of RVOT VT is ADO-insensitive, posing a diagnostic challenge. We present a peculiar case of an ADO-insensitive RVOT-VT storm and the challenges of recognizing and managing it in a resource-limited setting.